Governance Daiichi Sankyo Company, Limited

4568

JP3475350009

Pharmaceuticals

Delayed Japan Exchange Other stock markets 11:34:50 06/03/2026 am IST			5-day change	1st Jan Change
2,875.00 ^JPY	+1.09%		-6.14%	-14.10%

26/02	Daiichi Sankyo Company, Limited Announces Board Retirements, Effective March 31, 2026	CI
24/02	Avacta hails new data supporting proprietary preCision platform	AN

Executive Committee: Daiichi Sankyo Company, Limited

Manager

Positions heldSince

Hiroyuki Okuzawa

62 year

Chief Executive Officer	01/04/2025
President	01/04/2024

Ken Takeshita

Chief Tech/Sci/R&D Officer

Tomohiro Kodama

Comptroller/Controller/Auditor	-
Investor Relations Contact	-

Takashi Matsumoto

62 year

Human Resources Officer

01/04/2019

Composition of the Board of Directors: Daiichi Sankyo Company, Limited

Director

CommitteesSince

Sunao Manabe

71 year

Chairman

01/04/2023

Reiko Kinoshita

61 year

Director/Board Member	23/06/2025
Independent Dir/Board Member	23/06/2025

Akihiro Watanabe

67 year

Director/Board Member	23/06/2025
Independent Dir/Board Member	23/06/2025

Kenneth Joseph Keller

63 year

Director/Board Member

01/06/2025

Yo Honma

69 year

Director/Board Member	17/06/2024
Independent Dir/Board Member	17/06/2024

Takaaki Nishii

66 year

Director/Board Member	01/06/2023
Independent Dir/Board Member	01/06/2023

Takashi Matsumoto

62 year

Director/Board Member

17/06/2024

Yasuhiro Komatsu

68 year

Director/Board Member	01/06/2022
Independent Dir/Board Member	01/06/2022

Hiroyuki Okuzawa

62 year

Director/Board Member

21/06/2021

Latest Appointments: Daiichi Sankyo Company, Limited

26/02	Daiichi Sankyo Company, Limited Announces Board Retirements, Effective March 31, 2026	CI
24/02	Daiichi Sankyo Company, Limited Announces Executive Changes Effective from April 1, 2026	CI
20/02	Daiichi Sankyo Company, Limited Announces Executive Changes, Effective April 1, 2026	CI
22/01	Daiichi Sankyo Appoints Veronika Rozehnal, Ph.D., as Head of Translational Research Center Europe	CI
04/25/04	BP Chair to step down; AstraZeneca touts EU approval	AN
20/25/20	Immuneering Names Dr. Igor Matushansky, MD, PhD, as Chief Medical Officer	CI
03/25/03	Daiichi Sankyo Names CEO	MT

More news

Former Officers and Directors: Daiichi Sankyo Company, Limited

Insider

Positions held

SinceUntil

Toshiaki Sai

Director/Board Member	01/06/2015	21/06/2021
Director of Finance/CFO	01/06/2018	21/06/2021
Investor Relations Contact	-	-
Public Communications Contact	01/04/2008	01/06/2014
Corporate Officer/Principal	01/04/2012	01/06/2018

Toshiaki Tojo

Director/Board Member	01/06/2016	15/06/2020
Corporate Officer/Principal	01/04/2010	15/06/2020

Joji Nakayama

Director/Board Member	01/06/2010	01/04/2017
Chief Executive Officer	01/06/2010	01/06/2019
Chairman	01/04/2017	15/06/2020
President	01/06/2010	01/04/2017

Kazunori Hirokawa

Chief Administrative Officer	01/04/2015	18/06/2018
Director/Board Member	01/06/2010	18/06/2018
Chief Tech/Sci/R&D Officer	01/04/2007	01/04/2012
Corporate Officer/Principal	01/04/2012	01/04/2015

Shuji Handa

Corporate Officer/Principal

01/04/2017

Norimasa Kamura

Human Resources Officer

01/04/2017

Takeshi Ogita

Director/Board Member	01/06/2009	20/06/2016
Chief Tech/Sci/R&D Officer	01/04/2010	01/04/2014
Human Resources Officer	01/04/2009	01/04/2014
Corporate Officer/Principal	01/04/2014	01/04/2016
Sales & Marketing	08/10/2010	01/04/2014

Yuki Sato

Director/Board Member	01/06/2011	20/06/2016
Human Resources Officer	01/04/2014	01/04/2016
General Counsel	01/04/2014	01/04/2015
Corporate Officer/Principal	01/04/2007	01/06/2014

Manabu Sakai

Chief Administrative Officer	01/06/2014	22/06/2015
Director/Board Member	01/06/2014	22/06/2015
Director of Finance/CFO	08/10/2010	24/01/2012
Corporate Officer/Principal	24/01/2012	01/06/2014

Kazuo Koike

Comptroller/Controller/Auditor

04/07/2011

22/06/2015

Kunio Ishihara

Director/Board Member

08/10/2010

22/06/2015

Takashi Chiba

Comptroller/Controller/Auditor

04/07/2011

22/06/2015

Hiroshi Hirabayashi

Director/Board Member

08/10/2010

22/06/2015

Noritaka Uji

Director/Board Member	01/06/2014	15/06/2020
Chairman	15/06/2020	-
Independent Dir/Board Member	01/06/2014	-

Hiroshi Toda

Director/Board Member	01/06/2014	-
Independent Dir/Board Member	01/06/2014	-

Takashi Okimoto

Director/Board Member

06/01/2010

01/06/2012

Toru Kuroda

Corporate Officer/Principal

01/01/2000

01/06/2011

Jotaro Yabe

Director/Board Member

06/01/2010

28/06/2010

Kunio Nihira

Director/Board Member

06/01/2010

28/06/2010

Ryuzo Takada

Director/Board Member	06/01/2010	28/06/2010
Corporate Officer/Principal	06/01/2010	-
Sales & Marketing	06/01/2010	28/06/2010

Yuichiro Anzai

Director/Board Member

08/10/2010

Kiyoshi Morita

Chairman

06/01/2010

28/06/2010

Yoshifumi Nishikawa

Director/Board Member

06/01/2010

28/06/2010

Satoru Kimura

Director/Board Member	01/06/2019	-
Corporate Officer/Principal	21/06/2021	-
Sales & Marketing	01/04/2014	21/06/2021

Francis Plat

Corporate Officer/Principal

01/01/2005

01/01/2009

Katsumi Fujimoto

Director/Board Member	01/06/2016	-
Corporate Officer/Principal	01/04/2007	01/04/2019

Hideyuki Haruyama

Comptroller/Controller/Auditor	01/06/2015	-
Corporate Officer/Principal	01/04/2007	01/06/2015

Hitoshi Matsuda

Director/Board Member

06/01/2010

Akira Nagano

Public Communications Contact	24/01/2012	-
Corporate Officer/Principal	08/10/2010	24/01/2012

Ryoichi Watanabe

Comptroller/Controller/Auditor	01/04/2007	-
Director of Finance/CFO	01/04/2009	01/04/2015
Investor Relations Contact	01/04/2007	01/04/2016

Kazuyuki Watanabe

Comptroller/Controller/Auditor	01/06/2015	-
Public Communications Contact	01/06/2014	01/06/2015

Teruo Takayanagi

Comptroller/Controller/Auditor

06/01/2010

Hikaru Nagata

Comptroller/Controller/Auditor

08/10/2010

Tsutomu Une

Director/Board Member	04/07/2011	-
Corporate Officer/Principal	04/07/2011	30/04/2012

Takashi Shoda

Chairman	08/10/2010	-
Corporate Officer/Principal	08/10/2010	08/10/2010
President	26/05/2009	08/10/2010

Keiji Sawamukai

Corporate Officer/Principal

01/01/2001

Junichi Koga

Chief Tech/Sci/R&D Officer	-	01/04/2019
Corporate Officer/Principal	-	-

Kenji Inoue

Sales & Marketing

01/06/2014

Ryoji Nagasaka

Corporate Officer/Principal	-	01/04/2016
Corporate Secretary	01/04/2015	-

Kazuhiko Tanzawa

Corporate Officer/Principal

08/10/2010

Seiji Sugiyama

Director/Board Member

Audrey L. Hill

Corporate Officer/Principal

Ichiro Kanazawa

Director/Board Member

Shinichi Terano

Corporate Officer/Principal	04/07/2011	24/01/2012
Sales & Marketing	-	-

Katsuaki Miyoshi

Corporate Officer/Principal	04/07/2011	24/01/2012
Sales & Marketing	08/10/2010	-

Noriaki Ishida

Public Communications Contact	01/06/2014	-
Corporate Officer/Principal	08/10/2010	01/06/2014

Tomoo Yokoi

Comptroller/Controller/Auditor	08/10/2010	-
Director of Finance/CFO	08/10/2010	-
Corporate Officer/Principal	08/10/2010	08/10/2010

Haruhisa Kubota

Corporate Officer/Principal

08/10/2010

Ryoichi Kibushi

Sales & Marketing

08/10/2010

Kyohei Nonose

Human Resources Officer	08/10/2010	24/01/2012
Corporate Officer/Principal	24/01/2012	-

Glenn Gormley

Chief Tech/Sci/R&D Officer	-	31/03/2019
Corporate Officer/Principal	01/04/2019	-

Yoshikazu Takano

Chief Administrative Officer	24/01/2012	-
Public Communications Contact	08/10/2010	24/01/2012

Dalton Einhorn

Corporate Officer/Principal

Jeff Halperin

Corporate Officer/Principal

Satoshi Kunitada

Corporate Officer/Principal

08/10/2010

Age distribution of managers

Parity Men Women

Male	13
Female	1

Of which Executive Committee

Male	4
Female	0

Of which Directors

Male	8
Female	1

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Daiichi Sankyo Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The Company is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.

Employees

19,765

Sector

Pharmaceuticals

Calendar

30/03 - Ex-dividend date - 39 JPY

More about the company